HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Retained Earnings (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Retained Earnings came in at $1.5 billion in Q2 2026, up 0.77% year-over-year from $1.5 billion in Q2 2025, and little changed quarter-over-quarter from $1.5 billion in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Retained Earnings (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Retained Earnings for 12 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Retained Earnings rose 0.77% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 0.77% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, changed N/A from the prior year.
  • Retained Earnings was $1.5 billion for Q2 2026 at HUTCHMED (China), roughly flat from $1.5 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $1.5 billion in Q2 2026 and troughed at $1.5 billion in Q2 2022.
  • A 5-year average of $1.5 billion and a median of $1.5 billion in 2024 frame the typical range for Retained Earnings.
  • The widest YoY moves for Retained Earnings: up 5.09% in 2022, down 0.53% in 2022.
  • Over 5 years, Retained Earnings stood at $1.5 billion in 2022, then rose by 0.6% to $1.5 billion in 2023, then grew by 0.08% to $1.5 billion in 2024, then increased by 1.75% to $1.5 billion in 2025, then increased by 0.36% to $1.5 billion in 2026.
  • The last three Retained Earnings figures came in at $1.5 billion (Q2 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 211.51 Bn 197.52 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 181.48 Bn 178.30 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 132.45 Bn 124.60 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 82.87 Bn 74.88 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn 558.00 Mn
6 Moderna 54.72 Bn 49.59 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 30.31 Bn 30.31 Bn 1.16 Mn 5.13 Bn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.54 Bn
Dec 31, 2025 1.53 Bn
Jun 30, 2025 1.53 Bn
Jun 30, 2024 1.51 Bn
Jun 30, 2023 1.51 Bn
Dec 31, 2022 1.50 Bn
Jun 30, 2022 1.48 Bn
Dec 31, 2021 1.51 Bn
Jun 30, 2021 1.41 Bn
Mar 31, 2021 808.78 Mn
Dec 31, 2020 822.46 Mn
Jun 30, 2020 618.13 Mn
Dec 31, 2019 514.90 Mn
Sep 30, 2019 512.59 Mn
Jun 30, 2019 510.70 Mn
Mar 31, 2019 508.55 Mn
Dec 31, 2018 505.59 Mn
Jun 30, 2018 497.52 Mn
Dec 31, 2017 496.96 Mn
Jun 30, 2017 208.66 Mn